With skyrocketing demand for semaglutide and tirzepatide (popularized under brand names Ozempic, Wegovy, Zepbound, and Mounjaro), the stage was set for a compounding boom
Ozempic is used to help control and reduce high blood sugar levels, reducing the risk of type 2 diabetes complications such as heart disease
What makes an oral version possible is a clever piece of formulation science
REDEFINE 1 Phase 3 results (2025
Those who switched to placebo regained an average of around 14% of their body weight over the following 88 weeks, while those who stayed on tirzepatide continued to lose weight
A 2022 cohort study published in the Journal of Clinical Pharmacology found that 68% of first-time users report moderate-to-severe nausea in the first 72 hours, with symptom intensity peaking 90150 minutes post-injection